![Frontiers | Increased susceptibility to pneumonia due to tumour necrosis factor inhibition and prospective immune system rescue via immunotherapy Frontiers | Increased susceptibility to pneumonia due to tumour necrosis factor inhibition and prospective immune system rescue via immunotherapy](https://www.frontiersin.org/files/Articles/980868/fcimb-12-980868-HTML/image_m/fcimb-12-980868-g001.jpg)
Frontiers | Increased susceptibility to pneumonia due to tumour necrosis factor inhibition and prospective immune system rescue via immunotherapy
![Therapeutic potential of TNFα inhibitors in chronic inflammatory disorders: Past and future - ScienceDirect Therapeutic potential of TNFα inhibitors in chronic inflammatory disorders: Past and future - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2352304220300349-gr1.jpg)
Therapeutic potential of TNFα inhibitors in chronic inflammatory disorders: Past and future - ScienceDirect
Discovery of an Orally Active Small-Molecule Tumor Necrosis Factor-α Inhibitor | Journal of Medicinal Chemistry
![Figure 6. | Tumor Necrosis Factor and Anti-Tumor Necrosis Factor Therapies | The Journal of Rheumatology Figure 6. | Tumor Necrosis Factor and Anti-Tumor Necrosis Factor Therapies | The Journal of Rheumatology](https://www.jrheum.org/content/jrheumsupp/85/27/F6.large.jpg)
Figure 6. | Tumor Necrosis Factor and Anti-Tumor Necrosis Factor Therapies | The Journal of Rheumatology
![The Impact of Tumor Necrosis Factor Inhibitor Therapy for Psoriasis on Cardiovascular Risk - JDDonline - Journal of Drugs in Dermatology The Impact of Tumor Necrosis Factor Inhibitor Therapy for Psoriasis on Cardiovascular Risk - JDDonline - Journal of Drugs in Dermatology](http://dl.jddonline.com/articleimages/article_3064/table1.png)
The Impact of Tumor Necrosis Factor Inhibitor Therapy for Psoriasis on Cardiovascular Risk - JDDonline - Journal of Drugs in Dermatology
![Discovery of an Orally Active Small-Molecule Tumor Necrosis Factor-α Inhibitor | Journal of Medicinal Chemistry Discovery of an Orally Active Small-Molecule Tumor Necrosis Factor-α Inhibitor | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c00377/asset/images/medium/jm0c00377_0001.gif)
Discovery of an Orally Active Small-Molecule Tumor Necrosis Factor-α Inhibitor | Journal of Medicinal Chemistry
![Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease - The Lancet Rheumatology Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease - The Lancet Rheumatology](https://www.thelancet.com/cms/attachment/5a969640-08fc-4180-a9d2-9fe193686a83/gr1_lrg.jpg)
Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease - The Lancet Rheumatology
![TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management - Sara Jiayang Li, Lourdes M. Perez-Chada, Joseph F. Merola, 2019 TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management - Sara Jiayang Li, Lourdes M. Perez-Chada, Joseph F. Merola, 2019](https://journals.sagepub.com/cms/10.1177/2475530318810851/asset/images/large/10.1177_2475530318810851-fig1.jpeg)
TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management - Sara Jiayang Li, Lourdes M. Perez-Chada, Joseph F. Merola, 2019
![Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet's disease | Arthritis Research & Therapy | Full Text Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet's disease | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-019-1933-8/MediaObjects/13075_2019_1933_Fig1_HTML.png)
Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet's disease | Arthritis Research & Therapy | Full Text
![Pharmaceuticals | Free Full-Text | Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative? Pharmaceuticals | Free Full-Text | Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative?](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-15-00616/article_deploy/html/images/pharmaceuticals-15-00616-ag.png?1653377308)
Pharmaceuticals | Free Full-Text | Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative?
![Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatment | Nature Reviews Rheumatology Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatment | Nature Reviews Rheumatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrrheum.2017.187/MediaObjects/41584_2017_Article_BFnrrheum2017187_Fig1_HTML.jpg)